In April, Rascols team published research in the New England Journal of Medicine that found the GLP-1 drug lixisenatide reduced movement-related symptoms in people with early stage Parkinsons (2024, DOI: 10.1056/NEJMoa2312323)
Direct patients not to stop applying pressure after the 2 clicks When the yellow bar has stopped moving, the injection is complete
For those using GLP-1 medications, lifestyle support becomes even more important
Your provider will instruct you on how to administer these shots, and theyre available to answer questions or address any issues you have
In one 10 ml scoop, it provides a high dose of 2200 mg of L-carnitine
If you need low-FODMAP meals specifically, ModifyHealth has you covered there, too